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عالمات جديده بالعني ملتالزمة سنجاد سكايت
تقرير حالة من سلطنة عمان
اغا �سهاب حيدر، انورادا جاني�س، عديله الكندية، اأحمد الهنائي، ناديه اخلرو�سية، �سيف اليعربي، �سنا الزهيبية
abstract: Sanjad-Sakati syndrome (SSS; Online Mendelian Inheritance in Man [OMIM] #241410), also known 
as hypoparathyroidism-retardation-dysmorphism (HRD) syndrome, is an autosomal recessive disorder in which 
prenatal-onset extreme growth retardation, congenital hypoparathyroidism and craniofacial dysmorphism result 
from mutations in the tubulin-specific chaperone E (TBCE) gene on chromosome 1q42-43. We report unique 
ophthalmic findings in a two-year-old child with molecularly confirmed SSS, who was admitted to Sultan Qaboos 
University Hospital in Oman at 11 weeks old with bilateral congenital corneal clouding. The ophthalmic findings 
in this patient were linked to faulty microtubule assembly in the brain, abnormal intracellular membrane transport 
and the resulting metabolic derangement seen in patients with SSS. 
Keywords: Sanjad-Sakati Syndrome; TBCE Protein, human; Corneal Opacity, congenital; Persistent Fetal Vasculature 
Syndrome; Nanophthalmos; Hypoparathyroidism; Case Report; Oman. 
امللخ�ص: تعد متالزمة �سنجاد �سكاتي )SSS; OMIM #241410( واملعروفة اي�سا مبتالزمة ق�سور الدريقات-التخلف الذهني-العيوب اخللقية 
)HRD(، من الأمرا�س ذات ال�سفة املتنحية التي تظهريف فرتة ما قبل الولدة يف �سورة تاأخر �سديد يف النمو و ق�سور خلقي يف وظائف الدريقات وعيوب 
خلقية يف منطقة الوجه والراأ�س والذي ينتج عن طفرة وراثية يف اجلني اخلا�س بربوتني الأنابيب للم�ساحب �سيربون)E )TBCE على كرمو�سوم 1 اجلزء 
1q42-43. يف هذا البحث مت توثيق عالمات فريدة يف عني طفلة يف الثانية من العمر م�سابة مبتالزمة �سنجاد �سكاتي املثبتة علي امل�ستوى اجلزيئي 
الوراثي يف م�ست�سفي جامعة ال�سلطان قابو�س يف عمان. مت ربط هذه العالمات بخلل يف جتمع الأنابيب الدقيقه باملخ مع وجود خلل يف النقل عرب الأغ�سيه 
داخل اخللية وما ينتج عنه من اختالل يف عملية الي�س والذي يظهر يف مر�سى متالزمة �سنجاد �سكاتي.
ق�سور وظائف  العني؛  قزامة  اجلنينية؛  الدموية  الأوعيه  ا�ستمرارية  القرنيه،متالزمة  عتامة  بروتنيTBCE؛  �سكاتي؛  �سنجاد  الكلمات: متالزمة  مفتاح 
الدريقات؛ تقرير حالة؛ عمان.
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Sanjad-Sakati syndrome (SSS; Online Mendelian Inheritance in Man [OMIM] #241410), also known as hypoparathyroidism-
retardation-dysmorphism (HRD) syndrome, is an 
autosomal recessive chaperone disorder that is 
reported almost exclusively in patients of Arab 
ethnicity. First reported by Sanjad et al. in 1988,1 SSS 
is caused by mutations in the gene-encoding tubulin-
specific chaperone E (TBCE; RefSeq #NM_003193), 
located on chromosome 1q42.3.2,3 The disorder is 
characterised by congenital hypoparathyroidism 
leading to early onset hypocalcaemic seizures, 
prenatal onset of extreme growth retardation, mental 
retardation and craniofacial dysmorphism. Patients 
have a distinctive facies comprising of a narrow face, 
deep-set eyes, a beaked nose, large floppy ears, a thin 
upper lip and micrognathia.1,4 Various ocular anomalies, 
such as nanophthalmos, corneal opacification and 
retinal vascular tortuosity, have been reported in 
patients with SSS.5–7 This case report highlights unique 
ophthalmic findings of spontaneously resolving 
corneal opacities and persistent fetal vasculature in a 
two-year-old child with molecularly-confirmed SSS. 
A hypothesis is proposed that links the ophthalmic 
findings in this patient to faulty microtubule assembly, 
abnormal intracellular membrane transport and the 
resulting metabolic derangement distinctive to SSS. 
Case Report
An 11-week-old infant girl presented to the Sultan 
Qaboos University Hospital, Muscat, Oman, with 
bilateral cloudy corneas which had been noted since 
birth. The infant’s past medical history was significant 
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as she had severe growth retardation, with all growth 
parameters well below the third centile (weight: 4 kg; 
length: 48 cm; head circumference: 33 cm). The patient 
had had recurrent episodes of hypocalceamic seizures 
from the second week of life and recurrent hospital 
admissions for chest infections. She was the second 
child of consanguineous Omani parents and was born 
at 37 gestational weeks. She had a low birth weight 
of 1,500 g and was delivered by elective Caesarean 
section due to severe intrauterine growth retardation. 
A systemic review revealed a small-built infant with 
a beaked nose, long philtrum, thin upper lip, small 
pointed chin, large floppy ears and deep-set eyes. An 
ophthalmic examination of the patient showed normal 
vision at the light perception level, poor fixation and 
following in both eyes, with horizontal pendular, 
sensory nystagmus. An examination of the anterior 
segment showed diffuse, dense corneal opacification; 
however, no further symptoms were visible. 
On follow-up, the patient’s corneal opacification 
was found to have partially resolved, with an 
improvement in corneal clarity. At the age of three 
months, the infant was examined under general 
anesthaesia. This assessment revealed that she 
had bilateral nanophthalmos (the axial length of 
her right eye was 14 mm, while her left eye was 12 
mm) and central, patchy corneal opacification, with 
peripheral scleralisation and 360 degree pannus 
[Figure 1]. The anterior segments of the eyes were 
otherwise unremarkable. The pupillary reaction to 
light was difficult to determine due to her corneal 
opacity, but was believed to be sluggish in both eyes. 
An examination of the fundus revealed optic disc 
swelling and retinal vascular tortuosity in both eyes. 
The swelling was due to the presence of disc drusen 
in the right eye [Figure 2A]. In the left eye, the disc 
was dysplastic with extensive peripapillary gliosis. A 
papilomacular fold with shallow retinal detachment 
was seen in the posterior pole of the left eye [Figure 2B]. 
The intraocular pressure was 13 mmHg and 03 mmHg 
in the right and left eye, respectively. Features in the 
left eye were thought to be consistent with findings of 
persistent fetal vasculature (PFV) syndrome.
The child was later followed-up by clinical 
geneticists and paediatric endocrinologists. 
Biochemical investigations revealed low levels of 
parathyroid hormone (<0.1 pmol/L), with a low level 
of total calcium (1.97 mmol/L) and high levels of 
alkaline phosphatase (513 u/L) and phosphate (9.38 
mmol/L). A skeletal survey showed that the child 
had severe osteopenia. Consequently, a supportive 
treatment plan, including vitamin D supplementation 
and growth hormones, was commenced. 
This clinical and biochemical phenotype appearing 
in a consanguineous Omani family suggested the 
possibility of SSS. Thus, with the parents’ informed 
consent, molecular genetic testing (real-time 
polymerase chain reaction using the melting curve 
method) was carried out, using primers specific for the 
c.155-166 12 base pair deletion in the TBCE gene on 
chromosome 1q42.3. The c.156-166 deletion in exon 
3 was detected in both copies (homozygous) of the 
patient’s TBCE gene. As yet, all cases of SSS reported 
in the Middle East have the same 12 base pair deletion, 
confirming its founder effect.2,4 
Discussion
The TBCE gene governs the synthesis of 
acytoskeleton-associated protein glycine-rich (CAP-
Gly) domain at the N-terminus of the tubulin-folding 
cofactor E protein. This protein is required for 
microtubule assembly and stability and is ubiquitously 
 
Figure 2 A & B: RetCam (Clarity Medical Systems, 
Pleasanton, California, USA) images* of the (A) right 
and (B) left fundi. A: The right fundus shows a hyperemic 
elevated disc, tortuous retinal vessels and a tigroid 
appearance of the retina. B: The left fundus shows a large 
and dysplastic disc, peripapillary glial tissue extending 
temporaly from the disc and a papillomacular fold.
*Views are hazy due to residual corneal opacification. 
 
Figure 1: Image of the anterior segment of the patient’s 
left eye showing patchy corneal opacification with 
peripheral scelralisation and 360 degree pannus. A 
yellowish reflex can be seen in the pupil, indicating the 
presence of posterior segment anomalies.
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expressed in all cells of the body. The c.155-166 
deletion seen in this patient resulted in a deletion of 
four amino acids (p.Ser52-Glyc55del) in the CAP-
Gly domain of the TBCE transcript. This eliminated 
the highly conserved glycine, which is adjacent to 
the essential residue for alpha-tubulin binding. This 
can result in a generalised aberration of microtubular 
polarity, intracellular transport signal transduction 
and cellular migration, which would explain the 
pleiotropic manifestations of SSS.2 The homozygous 
deletions in the TBCE gene have also been reported 
in patients with Kenny-Caffey syndrome (KCS) type 1 
(OMIM #244460).2,6 This syndrome has a phenotype 
that resembles that of SSS but is characterised by 
slightly different clinical features, including normal 
intelligence, macrocephaly and deranged cell-
mediated immunity [Table 1]. It is likely that KCS type 
1 and SSS represent varying ends of the TBCE gene 
expression spectrum.3 
Microphthalmia, nanophthalmos, hypermetropia, 
disk swelling and tortuous retinal vessels attributed to 
hypermetropia, pseudoduplication of the optic disc 
and strabismus have been reported in cases of SSS.5,7,9 
Corneal opacities have been noted in individuals with 
SSS.7 However, their spontaneous resolution, as seen 
in the current patient, has not been reported. Other 
manifestations that have also not been previously 
described in SSS patients include posterior segment 
anomalies of PFV, such as disc dysplasia, peripapillary 
gliosis, papillomacular folds and shallow retinal 
detachment. In one study of eight patients with SSS, 
the predominant ocular finding was dense corneal 
opacities, abnormal retinal vessels and retinal vascular 
tortuosity.7 Papilloedema was reported in one patient, 
but no details were provided as to its cause.7 Similarly, 
no supporting figures were provided. Previous studies 
have attributed the disc swelling, and other posterior 
segment abnormalities, to the nanophthalmos.5,6 
The authors of this case report believe that the disc 
swelling and vessel tortuosity, as well as the other 
retinal findings seen in this patient, are features of 
PFV. This condition can influence, either primarily or 
secondarily, the appearance of the optic nerve head 
and macula. Tractional deformation by the adherent 
fibroblastic or glial tissue can cause malformations of 
the optic nerve and macula,10 as was also seen in the 
current patient. 
The pleotrophic disease manifestations of SSS and 
KCS are related to deranged tubulin physiology, which 
affects tissues with abundant microtubules, such as 
the brain.3 The ocular phenotype in SSS can also be 
explained in light of this knowledge. The authors 
of this case report postulate that mutations in the 
TBCE gene can cause a disturbance in microtubule 
function, which may explain the altered apoptosis 
and involution of the fetal vasculature. The tubulin 
microtubule system is known to play an important 
role in inducing the diverse signals responsible for the 
initiation of cell death.11 Corneal opacities in patients 
with SSS may be caused by corneal calcium deposition 
as a consequence of the metabolic abnormalities that 
are a hallmark of this disease. The transient nature 
and spontaneous partial resolution of the corneal 
opacification in the current patient may be attributed 
to the prompt initiation of therapy and the improved 
serum calcium and phosphate levels.
Table 1: A comparison of the characteristics of Sanjad-Sakati syndrome, Kenny-Caffey syndrome type 1 and the 
current case
Characteristic Sanjad-Sakati syndrome Kenny-Caffey syndrome type 1 Present case
Growth retardation Intrauterine and postnatal 
growth retardation
Postnatal growth retardation only Intrauterine and post-natal 
growth retardation
Mental characteristics Mental retardation Intellectually normal Mental retardation









Infections/immunology An increased 
susceptibility to infections 
in some patients due 
to hyposplenism 




immunity with recurrent 
bacterial infections
Recurrent infections; 
normal immune studies; 
but no detailed studies 
of polymorphonuclear 
or splenic function were 
reported 
Bone characteristics X-rays show 
demineralisation of bones; 
delayed bone age; there 
are reports of medullary 
stenosis and osteosclerosis 
in some patients
Osteosclerosis and thickening 
of long bones with medullary 
stenosis; absent diploic space in 
the skull bones
Demineralisation of bones; 
delayed bone age
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Conclusion
Unique ophthalmic findings of spontaneously 
resolving corneal opacities and PFV were observed in 
a two-year-old child with molecularly-confirmed SSS. 
A hypothesis is proposed to explain the pathogenesis 
of ocular anomalies seen in patients with SSS—the 
ophthalmic findings are thought to be caused by 
faulty microtubule assembly in the brain, abnormal 
intracellular membrane transport and the metabolic 
irregularities that are often seen in individuals with 
SSS. Reports of ocular findings in SSS patients are 
limited and the observations noted in this patient have 
not been previously reported.
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